Skip to content

Drug interactions

Doxorubicin + Tucatinib

Severity: Moderate

Doxorubicin and Tucatinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tucatinib inhibits CYP3A4 and may raise doxorubicin exposure, though doxorubicin is cleared mainly by other pathways including carbonyl reductase and P-gp. Higher exposure could worsen myelosuppression and cardiotoxicity.

What this interaction means in plain words

Doxorubicin and Tucatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Doxorubicin belongs to Oncology; Tucatinib belongs to Oncology.

Evidence level: Low

Why it happens

Tucatinib inhibits CYP3A4 and P-glycoprotein, potentially reducing doxorubicin clearance.

What to do

Monitor blood counts and cardiac status closely and consider doxorubicin dose reduction if toxicity develops. Prefer an alternative where practical.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Doxorubicin and Tucatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Doxorubicin with Tucatinib?

MediHelp rates the interaction as moderate. Doxorubicin and Tucatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Tucatinib inhibits CYP3A4 and may raise doxorubicin exposure, though doxorubicin is cleared mainly by other pathways including carbonyl reductase and P-gp. Higher exposure could worsen myelosuppression and cardiotoxicity.

How serious is the interaction between Doxorubicin and Tucatinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and cardiac status closely and consider doxorubicin dose reduction if toxicity develops. Prefer an alternative where practical.

What other medicines interact with Doxorubicin?

MediHelp also lists interactions of Doxorubicin with, for example, Adenovirus types 4 and 7 live, Belatacept, Cobicistat. The full list is on the Doxorubicin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in